Breast cancer is the second most common cancer and the second leading cause of cancer death among US women—and incidence rates remain on the rise. Diagnoses are happening in younger women, and for those who meet screening guidelines, 1 in 2 women are not receiving their recommended annual breast screenings.*

Addressing this devastating disease requires a broad, collaborative approach. At NOVARTIS, we’ve spent 30+ years advancing science and, together with our partners, we’re committed to inspiring meaningful change that goes beyond medicine.

“Your Attention Please” is a cornerstone of these efforts. By launching the campaign at the Super Bowl—one of the world’s biggest stages—we’re sparking a powerful conversation about breast health and inspiring true behavior change that drives early detection. Our campaign goal is to reach as many people as possible with science-backed guidance, culturally tailored resources, and practical tools that empower individuals to take charge of their breast health, understand their cancer risk, and get screened.

But attention without access isn’t enough and far too often, the cost of care stands between people and early detection. That’s why Susan G. Komen®, Novartis and advocacy partners across the country are also partnering to advance state and federal legislation that would help ensure affordable access to critical breast imaging that is necessary to diagnose breast cancer early, when it may be easier to treat.^†

This commitment to improving breast cancer outcomes goes even further, alongside health care providers, patients, additional advocacy partners, and the broader breast cancer community. NOVARTIS is championing transformative progress for those affected by the disease by:

•  

  •  

    • Leveraging cutting-edge technology to enhance clinical trial representation, enrollment efforts, and data collection to gather more accurate and relevant  scientific insights across geographies and patient demographics
       

    • Improving access and support across the breast cancer journey for patients from all communities and backgrounds
       

    • Bridging care gaps between people in historically underserved groups and providers in order to improve outcomes

With organizations like Susan G. Komen, TOUCH (The Black Breast Cancer Alliance), Living Beyond Breast Cancer, BreastCancer.org, and other leaders by our side, NOVARTIS is reimagining together, we are driving meaningful change—not just for today, but for generations to come.

* Estimates include women aged ≥40 between 2017-2021.
^† According to American Cancer Society Cancer Facts and Figures 2025.